Rationale and Design of a Randomized Controlled Trial Evaluating Whole Muscle Exercise Training Effects in Outpatients with Pulmonary Arterial Hypertension (WHOLEi+12)
BACKGROUND AND AIMS: Physical exercise is an important component in the management of pulmonary artery hypertension (PAH). The aim of this randomized controlled trial (RCT) is to determine the effects of an 8-week intervention combining muscle resistance, aerobic and inspiratory pressure load exercises in PAH outpatients.
METHODS: The RCT will be conducted from September 2015 to September 2016 following the recommendations of the Consolidated Standards of Reported Trials (CONSORT), with a total sample size of n ≥ 48 (≥24 participants/group). We will determine the effects of the intervention on: (i) skeletal-muscle power and mass (primary end points); and (ii) NT-proBNP, cardiopulmonary exercise testing variables (VO2peak, ventilatory equivalent for CO2 at the anaerobic threshold (VE/VCO2 at the AT), end-tidal pressure of CO2 at the anaerobic threshold (PETCO2 at the AT), 6-min walking distance (6MWD), maximal inspiratory pressure (PImax), health-related quality of life (HRQoL), objectively-assessed spontaneous levels of physical activity, and safety (secondary end points).
CONCLUSIONS AND PERSPECTIVES: This trial will provide insight into biological mechanisms of the disease and indicate the potential benefits of exercise in PAH outpatients, particularly on muscle power.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Cardiovascular drugs and therapy - 29(2015), 6 vom: 31. Dez., Seite 543-550 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sanchis-Gomar, Fabian [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardio-pulmonary exercise testing |
---|
Anmerkungen: |
Date Revised 18.03.2022 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1007/s10557-015-6623-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM254207227 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM254207227 | ||
003 | DE-627 | ||
005 | 20231224171859.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10557-015-6623-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n0847.xml |
035 | |a (DE-627)NLM254207227 | ||
035 | |a (NLM)26521182 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sanchis-Gomar, Fabian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rationale and Design of a Randomized Controlled Trial Evaluating Whole Muscle Exercise Training Effects in Outpatients with Pulmonary Arterial Hypertension (WHOLEi+12) |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 18.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a BACKGROUND AND AIMS: Physical exercise is an important component in the management of pulmonary artery hypertension (PAH). The aim of this randomized controlled trial (RCT) is to determine the effects of an 8-week intervention combining muscle resistance, aerobic and inspiratory pressure load exercises in PAH outpatients | ||
520 | |a METHODS: The RCT will be conducted from September 2015 to September 2016 following the recommendations of the Consolidated Standards of Reported Trials (CONSORT), with a total sample size of n ≥ 48 (≥24 participants/group). We will determine the effects of the intervention on: (i) skeletal-muscle power and mass (primary end points); and (ii) NT-proBNP, cardiopulmonary exercise testing variables (VO2peak, ventilatory equivalent for CO2 at the anaerobic threshold (VE/VCO2 at the AT), end-tidal pressure of CO2 at the anaerobic threshold (PETCO2 at the AT), 6-min walking distance (6MWD), maximal inspiratory pressure (PImax), health-related quality of life (HRQoL), objectively-assessed spontaneous levels of physical activity, and safety (secondary end points) | ||
520 | |a CONCLUSIONS AND PERSPECTIVES: This trial will provide insight into biological mechanisms of the disease and indicate the potential benefits of exercise in PAH outpatients, particularly on muscle power | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cardio-pulmonary exercise testing | |
650 | 4 | |a NT-proBNP | |
650 | 4 | |a Pulmonary disease | |
650 | 4 | |a Resistance exercise | |
650 | 4 | |a VO2peak | |
700 | 1 | |a González-Saiz, Laura |e verfasserin |4 aut | |
700 | 1 | |a Sanz-Ayan, Paz |e verfasserin |4 aut | |
700 | 1 | |a Fiuza-Luces, Carmen |e verfasserin |4 aut | |
700 | 1 | |a Quezada-Loaiza, Carlos A |e verfasserin |4 aut | |
700 | 1 | |a Flox-Camacho, Angela |e verfasserin |4 aut | |
700 | 1 | |a Santalla, Alfredo |e verfasserin |4 aut | |
700 | 1 | |a Munguía-Izquierdo, Diego |e verfasserin |4 aut | |
700 | 1 | |a Santos-Lozano, Alejandro |e verfasserin |4 aut | |
700 | 1 | |a Pareja-Galeano, Helios |e verfasserin |4 aut | |
700 | 1 | |a Ara, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Escribano-Subías, Pilar |e verfasserin |4 aut | |
700 | 1 | |a Lucia, Alejandro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cardiovascular drugs and therapy |d 1988 |g 29(2015), 6 vom: 31. Dez., Seite 543-550 |w (DE-627)NLM012606367 |x 1573-7241 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2015 |g number:6 |g day:31 |g month:12 |g pages:543-550 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10557-015-6623-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2015 |e 6 |b 31 |c 12 |h 543-550 |